Need a specific person's email?
Browse Renovo's employee directory (about 120 employees) and reveal verified emails free.
Renovo's most common email format is First.Last@renovo.com (ex. John.Doe@renovo.com), used for 100% of renovo.com addresses. Renovo uses 3 email patterns across 2 domains: renovo.com and renovo1.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of renovo.com |
|---|---|---|
| First.Last@renovo.comMost common | John.Doe@renovo.com |
| Format | Example | Share of renovo1.com |
|---|---|---|
| FLast@renovo1.comMost common | JDoe@renovo1.com | |
| Last@renovo1.com | Doe@renovo1.com |
Browse Renovo's employee directory (about 120 employees) and reveal verified emails free.
Biotechnology ResearchUnited Kingdom51-200 Employees
Renovo is a mid-sized biotechnology research company based in the United Kingdom. It concentrates on developing targeted oncology therapies and commercializing RenovoCath, an FDA-cleared drug-delivery device. The firm aims to improve cancer treatment by enabling localized delivery of chemotherapeutics to tumors, potentially increasing local potency while reducing systemic exposure. Its activities include platforms and approaches designed to support intra-arterial delivery of cancer drugs. The primary customers are oncology clinicians and healthcare organizations seeking more precise, localized cancer therapies. In 2026, the company announced that oxaliplatin received FDA orphan-drug designation for the treatment of pancreatic cancer, marking a regulatory milestone for its pipeline.
Most common format
First.Last@renovo.com
Example: John.Doe@renovo.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.